Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Neurological Disorders Trials
Contact Name Clinical Trials at Rush
Contact Phone (312) 942-5498
Contact E-mail clinical_trials@rush.edu

Click on links below to learn about clinical research trials for neurological disorders. Trials listed may include studies of new surgical techniques, new medications or new treatment methods. If no studies are listed, call (312) 942-5498 to inquire about studies. If you would like to schedule an appointment with a physician at Rush, call (888) 352-RUSH, our toll-free referral line.

Included in this section:

A Randomized Multicenter Clinical Trial of Unruptured Brain AVMs (ARUBA): A Randomized Multicenter Clinical Trial of Unruptured Brain AVMs (ARUBA)

Cervical Dystonia Study: Treatment for Cervical Dystonia

Creatine Safety, Tolerability and Efficacy in Huntington's Disease: CREST-E

Creatine and Parkinson's Study: Creatine and Parkinson's Study

Deep Brain Stimulation Study: A new system for deep brain stimulation and Parkinson's disease

Early Parkinson Disease Research Medication Study: STEADY-PD

Epilepsy Examination Study: The Molecular Biology of Epileptogenesis

Epilepsy Phenome/Genome Project(EPGP): Epilepsy Phenome/Genome Project(EPGP)

Epilepsy and Depression (Interictal Dysphoric Disorder): Study to evaluate the safety and efficacy of medication in the treatment of a form of depression in epilepsy known as interictal dysphoric disorder with or without postictal depressive symptoms.

Epilepsy and Mood: The purpose of this research study is to determine if a particular antiepileptic medication may have these same positive results as some of the other antiepileptic drugs have produced on mood.

Fragile X Study: Premutation Carriers: Neurological phenotype in FMR1 premutation carriers

Fragile X Syndrome: Clinical Trial of STX209 for the Treatment of Irritability and Aggression: This is a clinical trial of STX209, which contains only the active form of the two drug forms that are in the drug baclofen which is used to treat irritability and aggression in people with fragile X syndrome (FXS), thus STX209 may be more helpful for people with FXS who have these symptoms.

Huntington's Disease Study: Effects of coenzyme Q10 on progression of functional decline in Huntington's disease

Intracerebral Hemorrhage Study: Minimally Invasive Surgery Plus rt-PA for ICH Evacuation (MISTIE)

Ischemic Stroke Prevention Study: Study of stenting plus medical management compared to medical management alone in preventing recurrence of ischemic stroke

Moyamoya Disease Study: The Role of Cerebral Hemodynamics in Moyamoya Disease

Parkinson's Disease Cognitive Impairment Study: Parkinson's disease, cognitive impairment, and structural MRI

Parkinson's Disease Eye Safety Study: A two-year, open label, randomized, parallel group, blinded assessment ophthalmologic safety study of pramipexole ir versus ropinirole in early Parkinson's disease patients

Parkinson's Disease Genetics Study: Genetic epidemiology of Parkinson's disease (Consortium on Risk for Early-onset PD: CORE-PD)

Parkinson's Disease Investigational Drug Study: Study of an extended-release investigational drug for the treatment of Parkinson's disease

Parkinson's Disease and Erectile Dysfunction: A randomized, double-blind, placebo-controlled study of sildenafil (Viagra) in Parkinson's disease men with erectile dysfunction

Parkinson's Disease and Sleep Disturbance Study: A study of the treatment of hallucinations and sleep disturbances in Parkinson's disease

Pharmacokinetics and Pharmacodynamics of Treatment Drugs for Parkinson's Disease: A Study to Comparing Pharmacokinetics and Pharmacodynamics of an Investigational Drug to Standard Carbidopa-Levodopa

The Insulin Resistance Intervention After Stroke Trial (IRIS): The Insulin Resistance Intervention After Stroke Trial (IRIS)

Tourette Syndrome Study: Safety and effectiveness study of an investigational medication for children with Tourette Syndrome

Using Computer Software to Study Alzheimer's Disease: Study to evaluate the ability of a novel software program to diagnose and track the progression of Alzheimer's disease using MEG/EEG



Promotional Information

Clinical Trials Home
Neurological Disorders Trials
Cervical Dystonia Study
Creatine Safety, Tolerability and Efficacy in Huntington's Disease
Creatine and Parkinson's Study
Deep Brain Stimulation Study
Early Parkinson Disease Research Medication Study
Epilepsy Examination Study
Epilepsy Phenome/Genome Project
Epilepsy and Depression (Interictal Dysphoric Disorder)
Epilepsy and Mood
Fragile X Study: Premutation Carriers
Fragile X Syndrome: Clinical Trial of STX209 for the Treatment of Irritability and Aggression
Huntington's Disease Study
Intracerebral Hemorrhage Study
Ischemic Stroke Prevetion Study
Moyamoya Disease Study
Parkinson's Disease Cognitive Impairment Study
Parkinson's Disease Eye Safety Study
Parkinson's Disease Genetics Study
Parkinson's Disease Investigational Drug Study
Parkinson's Disease and Erectile Dysfunction
Parkinson's Disease and Sleep Disturbance
Pharmacokinetics and Pharmacodynamics of Treatment Drugs for Parkinson's Disease
The Insulin Resistance Intervention after Stroke Trial
Tourette Syndrome Study
Unruptured Brain Arteriovenous Malformation Study
Using Computer Software to Study Alzheimer's Disease

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612